Navigation Links
Transcept Pharmaceuticals to Present at the BioCentury Thomson Reuters Newsmakers in the Biotech Industry Conference on September 16, 2009
Date:9/2/2009

RICHMOND, Calif., Sept. 2 /PRNewswire-FirstCall/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) today announced that it will present at the BioCentury Thomson Reuters Newsmakers in the Biotechnology Industry Conference on Wednesday, September 16, 2009 at 11:00 am EDT.

A live audio webcast and replay of the presentation will be available on the investor webpage at www.transcept.com.

About Transcept

Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in neuroscience. The most advanced Transcept product candidate is Intermezzo(R) (zolpidem tartrate sublingual tablet), which is currently being reviewed by the U.S. Food and Drug Administration (FDA) as a prescription sleep aid for use in the middle of the night at the time a patient awakens and has difficulty returning to sleep. October 30, 2009 is the PDUFA target date for the FDA to take action on its review of the Intermezzo(R) NDA. Transcept and Purdue Pharmaceutical Products, L.P. have entered into a collaboration agreement for the development and commercialization of Intermezzo(R) in the United States. For further information, please visit the company's website at: www.transcept.com.

About Intermezzo(R)

Intermezzo(R) (zolpidem tartrate sublingual tablet), the lead product candidate at Transcept, has the potential to be the first prescription sleep aid specifically approved for use in the middle of the night at the time a
'/>"/>

SOURCE Transcept Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. Sign Exclusive Agreement to Commercialize Intermezzo(R) in the United States
2. Transcept Pharmaceuticals to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference
3. Transcept Pharmaceuticals to Present at 11th Annual BIO CEO & Investor Conference
4. Transcept Pharmaceuticals Announces FDA Acceptance for Review of New Drug Application for Intermezzo(R)
5. Transcept Pharmaceuticals, Inc. to Present at the Natixis Bleichroeder Second Annual Hidden Gems Conference
6. Transcept Pharmaceuticals Appoints Key Senior Executives
7. Transcept Pharmaceuticals to Participate in Middle-of-the-Night (MOTN) Insomnia Investor Panel
8. Poniard Pharmaceuticals To Present at Three Upcoming Investor Conferences in September
9. Optimer Pharmaceuticals Announces Presentations of Additional Phase 3 Fidaxomicin and Prulifloxacin Data at Upcoming ICAAC Annual Meeting
10. Jiangbo Pharmaceuticals to Present at Rodman & Renshaw Annual Global Investment Conference
11. Access Pharmaceuticals to Present at the Rodman & Renshaw Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... 2015 Genes in Space, a nation-wide ... landing at New England Biolabs® (NEB®) along with ... scientific exploration and celebration, on Thursday, July 9 ... Boeing®, The Center for Advancement of Science in ... to design an experiment to solve a real-life ...
(Date:7/7/2015)... , ... July 07, 2015 , ... ... detection using INSTI HIV-1/HIV-2 Antibody Test was accepted for presentation at the 8th ... Vancouver. The results will be presented Wednesday, July 22nd from 1:00 pm to ...
(Date:7/7/2015)... OKLAHOMA CITY , July 7, 2015 /PRNewswire/ ... of a two-year, $300,000 matching grant from the ... Technology (OCAST). This grant supports the development and ... identify autoantibodies directed against neuronal antigens in patients ... and schizophrenia. Such panels are intended to assist ...
(Date:7/7/2015)... ... July 07, 2015 , ... CSM, a leading clinical trial ... President of Finance. Morse has an extensive background in financial management and accounting, bringing ... team. In his new role, Morse will oversee all financial areas of the company ...
Breaking Biology Technology:Genes in Space finalists attend laboratory workshop and celebration at New England Biolabs' headquarters 2bioLytical to Present Findings of Early HIV Detection 2bioLytical to Present Findings of Early HIV Detection 3Moleculera Labs Receives Grant from OCAST to Develop Assays to Identify Individuals with Neuropsychiatric Disorders of Autoimmune Origin 2Moleculera Labs Receives Grant from OCAST to Develop Assays to Identify Individuals with Neuropsychiatric Disorders of Autoimmune Origin 3CSM Appoints Michael Morse as Vice President of Finance 2
... Wisconsin Health Information Exchange has been awarded an ... Wisconsin for calendar year 2006. , ,The funds ... 501c3 entity, to develop its governance structure and administrative ... health events through sharp increases in emergency room traffic, ...
... - Metavante Corp ., the banking and payments ... is in the final stages of acquiring VICOR, ... processing software. , ,VICOR is being pursued, in part, ... to its client financial institutions so they can address ...
... Wis. – Prodesse Inc. , a biotechnology ... for the testing of infectious diseases, has entered into ... , the Basel, Switzerland-based pharmaceutical firm. , ,Under the ... the right to include Roche enzymes in its products. ...
Cached Biology Technology:WHIE receives state eHealth Initiative contract 2
(Date:6/23/2015)... 2015 Research and ... the "Body-Worn Temperature Sensors Market - Global ... 2014 - 2020" report to their offering. ... the global body-worn temperature sensors market. The global ... the basis of types, care setting, patient demographic, ...
(Date:6/23/2015)... PALM BEACH GARDENS, Fla. , June ... of multi-factor identity management and authentication solutions, today ... Altus strong, multi-factor authentication solution.  The ... ease of use of the DigitalPersona Altus ... and biometric reader compatibility. In ...
(Date:6/18/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... mobile commerce market announces that its Wocket® smart wallet will ... the Mark", scheduled to air on WABC Radio (am770) in ... . The broadcast air- time for the ... EST. NXT-ID, Inc.,s CEO Gino Pereira will be ...
Breaking Biology News(10 mins):Body-Worn Temperature Sensors Market - Global Industry Analysis 2Crossmatch Releases Enhanced DigitalPersona Altus Advanced Authentication Functionality 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 3
... derived from honeybee hives arrests the growth of prostate cancer ... from researchers at the University of Chicago Medicine. Caffeic ... honeybee hive propolis, the resin used by bees to patch ... as a natural remedy for conditions ranging from sore throats ...
... three or more feet in diameter accounted for nearly ... site, yet represented only one percent of the trees ... fir, sugar pine and incense cedars per acre at ... carbon dioxide into plant tissue and sequestering that carbon ...
... of the most of the spectacular traits in nature: the ... on walruses and antlers on moose. Sexual conflict the ... to be a particularly potent force in driving the evolution ... genetic processes responsible for producing such traits are not well ...
Cached Biology News:Beehive extract shows potential as prostate cancer treatment 2Beehive extract shows potential as prostate cancer treatment 3Handful of heavyweight trees per acre are forest champs 2Handful of heavyweight trees per acre are forest champs 3Biologists turn back the clock to understand evolution of sex differences 2
... a base medium for preparation of minimal and ... but does not contain amino acids. Both bulk ... pouch contains reagents to prepare 500 ml of ... of 10X YNB for S. cerevisiae media. Store ...
... Progesterone Receptor (PR) Competitor Assay Kits ... novel progesterone receptor binding compounds using ... utilizes a fusion of glutathione transferase ... human progesterone receptor [PR-LBD(GST)] and a ...
... Protein G bind specifically to Fc regions ... Protein G conjugates are commonly used as ... immunoglobulin subtypes from serum, hybridoma ascites fluids, ... These reagents are also commonly used to ...
... the first instrument engineered to match the ... by thousands of research centers worldwide. It ... which are ideally suited for high-speed temperature ... extremely high surface-area-to-volume ratio. ,By combining glass ...
Biology Products: